Prime

Novartis delivers Sh150 per month drugs for diabetes, cancer patients

Former Health secretary James Macharia (right) with Novartis board of directors chairman Joerg Reinhardt at the launch of Novartis Access in Nairobi last October. PHOTO | GERALD ANDERSON

Patients suffering from respiratory and non-communicable illnesses such as breast cancer, cardiovascular diseases and diabetes can now access the Sh150-per-month drugs by pharmaceutical company Novartis, which delivered the first shipment on Wednesday last week. 

The global pharmaceutical giant had in October announced the special offer for patients who cannot afford to buy drugs for respiratory and non-communicable diseases (NCDs).

PAYE Tax Calculator

Note: The results are not exact but very close to the actual.

Get it First!

Stay up to date on the editors' picks of the week.

Latest

  1. PRIME Public participation: Beyond the tick-box

  2. AI is reshaping our architecture, but culture must remain at the centre

  3. PRIME When grandma’s cooking meets Nairobi’s fine dining

  4. What Kenya boards must learn from London Saxon Woods ruling

In the headlines

View All